nodes	percent_of_prediction	percent_of_DWPC	metapath
Tofisopam—Verapamil—hypertension	0.416	1	CrCtD
Tofisopam—Papaverine—Verapamil—hypertension	0.186	1	CrCrCtD
Tofisopam—PDE3A—hypertension	0.137	0.575	CbGaD
Tofisopam—PDE4A—hypertension	0.101	0.425	CbGaD
Tofisopam—CYP3A4—Guanethidine—hypertension	0.00896	0.11	CbGbCtD
Tofisopam—CYP3A4—Hydralazine—hypertension	0.00679	0.0837	CbGbCtD
Tofisopam—CYP3A4—Guanfacine—hypertension	0.00577	0.0712	CbGbCtD
Tofisopam—CYP3A4—Isradipine—hypertension	0.00514	0.0634	CbGbCtD
Tofisopam—CYP3A4—Nisoldipine—hypertension	0.00453	0.0559	CbGbCtD
Tofisopam—CYP3A4—Indapamide—hypertension	0.00453	0.0559	CbGbCtD
Tofisopam—CYP3A4—Eplerenone—hypertension	0.00437	0.0539	CbGbCtD
Tofisopam—CYP3A4—Diltiazem—hypertension	0.00437	0.0539	CbGbCtD
Tofisopam—CYP3A4—Enalapril—hypertension	0.0039	0.0481	CbGbCtD
Tofisopam—CYP3A4—Irbesartan—hypertension	0.00357	0.044	CbGbCtD
Tofisopam—CYP3A4—Amlodipine—hypertension	0.0035	0.0431	CbGbCtD
Tofisopam—CYP3A4—Felodipine—hypertension	0.00337	0.0416	CbGbCtD
Tofisopam—CYP3A4—Nifedipine—hypertension	0.00326	0.0402	CbGbCtD
Tofisopam—CYP3A4—Carvedilol—hypertension	0.00321	0.0396	CbGbCtD
Tofisopam—CYP3A4—Nicardipine—hypertension	0.00321	0.0396	CbGbCtD
Tofisopam—CYP3A4—Propranolol—hypertension	0.00295	0.0364	CbGbCtD
Tofisopam—CYP3A4—Clonidine—hypertension	0.00282	0.0348	CbGbCtD
Tofisopam—CYP3A4—Atorvastatin—hypertension	0.00251	0.031	CbGbCtD
Tofisopam—CYP3A4—Losartan—hypertension	0.0023	0.0283	CbGbCtD
Tofisopam—CYP3A4—Verapamil—hypertension	0.00203	0.025	CbGbCtD
Tofisopam—PDE2A—cardiac ventricle—hypertension	0.0011	0.0693	CbGeAlD
Tofisopam—PDE10A—nephron tubule—hypertension	0.000759	0.0478	CbGeAlD
Tofisopam—PDE2A—adrenal cortex—hypertension	0.000747	0.0471	CbGeAlD
Tofisopam—PDE2A—heart—hypertension	0.000722	0.0455	CbGeAlD
Tofisopam—PDE10A—heart—hypertension	0.000722	0.0455	CbGeAlD
Tofisopam—PDE10A—decidua—hypertension	0.000703	0.0443	CbGeAlD
Tofisopam—PDE2A—decidua—hypertension	0.000703	0.0443	CbGeAlD
Tofisopam—PDE2A—cardiovascular system—hypertension	0.000682	0.0429	CbGeAlD
Tofisopam—PDE2A—cortex of kidney—hypertension	0.00065	0.0409	CbGeAlD
Tofisopam—Papaverine—PDE3A—hypertension	0.000641	0.365	CrCbGaD
Tofisopam—PDE3A—cardiac ventricle—hypertension	0.000626	0.0395	CbGeAlD
Tofisopam—PDE2A—cardiac atrium—hypertension	0.000618	0.0389	CbGeAlD
Tofisopam—PDE3A—myocardium—hypertension	0.000589	0.0371	CbGeAlD
Tofisopam—PDE2A—medulla oblongata—hypertension	0.000582	0.0367	CbGeAlD
Tofisopam—PDE2A—adrenal gland—hypertension	0.000539	0.034	CbGeAlD
Tofisopam—PDE10A—adrenal gland—hypertension	0.000539	0.034	CbGeAlD
Tofisopam—CYP3A4—urine—hypertension	0.000514	0.0324	CbGeAlD
Tofisopam—PDE4A—heart—hypertension	0.000497	0.0313	CbGeAlD
Tofisopam—PDE4A—decidua—hypertension	0.000484	0.0305	CbGeAlD
Tofisopam—PDE2A—endocrine gland—hypertension	0.000468	0.0295	CbGeAlD
Tofisopam—PDE2A—central nervous system—hypertension	0.000421	0.0265	CbGeAlD
Tofisopam—PDE10A—central nervous system—hypertension	0.000421	0.0265	CbGeAlD
Tofisopam—PDE3A—heart—hypertension	0.000411	0.0259	CbGeAlD
Tofisopam—PDE3A—smooth muscle tissue—hypertension	0.000408	0.0257	CbGeAlD
Tofisopam—Colchicine—ABCC1—hypertension	0.000394	0.225	CrCbGaD
Tofisopam—PDE3A—cardiovascular system—hypertension	0.000388	0.0244	CbGeAlD
Tofisopam—PDE4A—adrenal gland—hypertension	0.000371	0.0234	CbGeAlD
Tofisopam—PDE3A—cardiac atrium—hypertension	0.000352	0.0222	CbGeAlD
Tofisopam—PDE3A—adrenal gland—hypertension	0.000307	0.0193	CbGeAlD
Tofisopam—PDE3A—endocrine gland—hypertension	0.000266	0.0168	CbGeAlD
Tofisopam—Verapamil—KCNJ11—hypertension	0.000195	0.111	CrCbGaD
Tofisopam—Verapamil—ABCC1—hypertension	0.000176	0.101	CrCbGaD
Tofisopam—Verapamil—CYP2C18—hypertension	0.000163	0.093	CrCbGaD
Tofisopam—CYP3A4—kidney—hypertension	0.000122	0.00766	CbGeAlD
Tofisopam—Verapamil—CYP3A5—hypertension	0.000107	0.0613	CrCbGaD
Tofisopam—CYP3A4—endocrine gland—hypertension	8.53e-05	0.00537	CbGeAlD
Tofisopam—Verapamil—SLC6A4—hypertension	7.71e-05	0.044	CrCbGaD
Tofisopam—CYP3A4—central nervous system—hypertension	7.69e-05	0.00484	CbGeAlD
Tofisopam—PDE4A—Signaling Pathways—YWHAZ—hypertension	3.1e-06	5.13e-05	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—MTOR—hypertension	3.09e-06	5.12e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—ADCY5—hypertension	3.08e-06	5.1e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—SPP1—hypertension	3.06e-06	5.07e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—NGF—hypertension	3.06e-06	5.07e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PRKCG—hypertension	3.06e-06	5.07e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—CXCL8—hypertension	3.05e-06	5.05e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—ITGB3—hypertension	3.04e-06	5.03e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PRKCA—hypertension	3.04e-06	5.03e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—YWHAZ—hypertension	3.01e-06	4.99e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CCR5—hypertension	2.98e-06	4.93e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—PRKCD—hypertension	2.98e-06	4.93e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—NGF—hypertension	2.98e-06	4.93e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—SPP1—hypertension	2.98e-06	4.93e-05	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CXCL8—hypertension	2.97e-06	4.92e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—CXCL8—hypertension	2.97e-06	4.91e-05	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—MYC—hypertension	2.93e-06	4.86e-05	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—TGFB1—hypertension	2.92e-06	4.84e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—HTR2A—hypertension	2.92e-06	4.83e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—C3—hypertension	2.91e-06	4.82e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PRKCD—hypertension	2.9e-06	4.8e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CCR5—hypertension	2.9e-06	4.8e-05	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—AKT1—hypertension	2.87e-06	4.76e-05	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—EGFR—hypertension	2.87e-06	4.75e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—HTR2A—hypertension	2.84e-06	4.7e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—PDGFB—hypertension	2.83e-06	4.69e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—C3—hypertension	2.83e-06	4.69e-05	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—IL6—hypertension	2.83e-06	4.68e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—FGFR1—hypertension	2.82e-06	4.67e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—HIF1A—hypertension	2.78e-06	4.6e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—AGT—hypertension	2.77e-06	4.58e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PDGFB—hypertension	2.76e-06	4.57e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—FGFR1—hypertension	2.74e-06	4.54e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CALM1—hypertension	2.72e-06	4.51e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—LEP—hypertension	2.71e-06	4.49e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—APOE—hypertension	2.71e-06	4.49e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—HIF1A—hypertension	2.7e-06	4.47e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—AGT—hypertension	2.69e-06	4.46e-05	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—MMP9—hypertension	2.69e-06	4.45e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CAV1—hypertension	2.69e-06	4.45e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—APOA1—hypertension	2.68e-06	4.44e-05	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CDKN1A—hypertension	2.68e-06	4.44e-05	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—AKT1—hypertension	2.68e-06	4.44e-05	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—PTEN—hypertension	2.67e-06	4.43e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—KDR—hypertension	2.66e-06	4.4e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CALM1—hypertension	2.65e-06	4.38e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—LEP—hypertension	2.64e-06	4.37e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—APOE—hypertension	2.64e-06	4.37e-05	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—MAPK8—hypertension	2.62e-06	4.33e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CAV1—hypertension	2.61e-06	4.33e-05	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—AKT1—hypertension	2.61e-06	4.32e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—APOA1—hypertension	2.61e-06	4.32e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—KDR—hypertension	2.58e-06	4.28e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—FN1—hypertension	2.56e-06	4.23e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—F2—hypertension	2.56e-06	4.23e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—PRKCB—hypertension	2.56e-06	4.23e-05	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—EP300—hypertension	2.55e-06	4.22e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—HAS1—hypertension	2.53e-06	4.19e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—HAS3—hypertension	2.53e-06	4.19e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PNMT—hypertension	2.53e-06	4.19e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—HYAL2—hypertension	2.53e-06	4.19e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—HAS2—hypertension	2.53e-06	4.19e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—QDPR—hypertension	2.53e-06	4.19e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Biological oxidations—POMC—hypertension	2.52e-06	4.18e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—NOTCH1—hypertension	2.5e-06	4.14e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—F2—hypertension	2.49e-06	4.12e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—FN1—hypertension	2.49e-06	4.12e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PRKCB—hypertension	2.49e-06	4.12e-05	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—SRC—hypertension	2.48e-06	4.11e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—NOTCH1—hypertension	2.43e-06	4.03e-05	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—VEGFA—hypertension	2.41e-06	4e-05	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—TP53—hypertension	2.41e-06	3.99e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GSTA5—hypertension	2.38e-06	3.94e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—POMC—hypertension	2.33e-06	3.86e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—INS—hypertension	2.32e-06	3.84e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CCL2—hypertension	2.28e-06	3.77e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—POMC—hypertension	2.26e-06	3.75e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—HYAL1—hypertension	2.25e-06	3.73e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—MDH1—hypertension	2.25e-06	3.73e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GSTT2—hypertension	2.25e-06	3.73e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CPS1—hypertension	2.25e-06	3.73e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CDO1—hypertension	2.25e-06	3.73e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—INS—hypertension	2.25e-06	3.73e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—IGF1—hypertension	2.24e-06	3.71e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—AKT2—hypertension	2.24e-06	3.71e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—EGFR—hypertension	2.23e-06	3.69e-05	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—MYC—hypertension	2.22e-06	3.68e-05	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—TGFB1—hypertension	2.22e-06	3.67e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CCL2—hypertension	2.22e-06	3.67e-05	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—IL6—hypertension	2.2e-06	3.65e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—IGF1—hypertension	2.18e-06	3.61e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—AKT2—hypertension	2.18e-06	3.61e-05	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—EGFR—hypertension	2.17e-06	3.6e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—EGFR—hypertension	2.17e-06	3.59e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CYP4F12—hypertension	2.15e-06	3.56e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GCH1—hypertension	2.15e-06	3.56e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—SERPINE1—hypertension	2.13e-06	3.52e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—SERPINE1—hypertension	2.07e-06	3.43e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PLCD1—hypertension	2.06e-06	3.42e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—FGF2—hypertension	2.06e-06	3.41e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—RHOA—hypertension	2.05e-06	3.4e-05	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—AKT1—hypertension	2.03e-06	3.37e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—NOS3—hypertension	2.03e-06	3.36e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—PIK3R1—hypertension	2.03e-06	3.36e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—FGF2—hypertension	2e-06	3.32e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—RHOA—hypertension	2e-06	3.31e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—AHCY—hypertension	1.98e-06	3.29e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CYP11B1—hypertension	1.98e-06	3.29e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PIK3R1—hypertension	1.98e-06	3.27e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—NOS3—hypertension	1.98e-06	3.27e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—DBH—hypertension	1.92e-06	3.18e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GSTM5—hypertension	1.92e-06	3.18e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—EPHX2—hypertension	1.92e-06	3.18e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ALOX12—hypertension	1.92e-06	3.18e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GBA—hypertension	1.92e-06	3.18e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—RELA—hypertension	1.91e-06	3.17e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—MTOR—hypertension	1.87e-06	3.1e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—RELA—hypertension	1.86e-06	3.08e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CYP2J2—hypertension	1.86e-06	3.08e-05	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—TP53—hypertension	1.82e-06	3.02e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—MTOR—hypertension	1.82e-06	3.02e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ARG1—hypertension	1.8e-06	2.99e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—DECR1—hypertension	1.8e-06	2.99e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GLS2—hypertension	1.8e-06	2.99e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—COX5B—hypertension	1.8e-06	2.99e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CXCL8—hypertension	1.8e-06	2.98e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CXCL8—hypertension	1.75e-06	2.9e-05	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—AKT1—hypertension	1.74e-06	2.88e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—IL6—hypertension	1.71e-06	2.84e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ALAD—hypertension	1.71e-06	2.83e-05	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—AKT1—hypertension	1.69e-06	2.8e-05	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—IL6—hypertension	1.67e-06	2.77e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—IL6—hypertension	1.67e-06	2.76e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PLCE1—hypertension	1.63e-06	2.7e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—STS—hypertension	1.63e-06	2.7e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ALDH7A1—hypertension	1.63e-06	2.7e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—MMP9—hypertension	1.63e-06	2.7e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CDKN1A—hypertension	1.62e-06	2.69e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—PTEN—hypertension	1.62e-06	2.68e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—MMP9—hypertension	1.58e-06	2.63e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—MAPK8—hypertension	1.58e-06	2.62e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—AKT1—hypertension	1.58e-06	2.62e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CDKN1A—hypertension	1.58e-06	2.62e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PTEN—hypertension	1.58e-06	2.61e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CBS—hypertension	1.56e-06	2.59e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CYP4A11—hypertension	1.56e-06	2.59e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ARG2—hypertension	1.56e-06	2.59e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—EP300—hypertension	1.54e-06	2.56e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—MAPK8—hypertension	1.54e-06	2.55e-05	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—AKT1—hypertension	1.54e-06	2.55e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—AKT1—hypertension	1.54e-06	2.55e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—XDH—hypertension	1.53e-06	2.54e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PTGIS—hypertension	1.5e-06	2.49e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CYP3A5—hypertension	1.5e-06	2.49e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—SLC5A2—hypertension	1.5e-06	2.49e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—EP300—hypertension	1.5e-06	2.49e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—SRC—hypertension	1.5e-06	2.49e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—VEGFA—hypertension	1.46e-06	2.42e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—SRC—hypertension	1.46e-06	2.42e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—TPH1—hypertension	1.45e-06	2.41e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—HSD11B1—hypertension	1.45e-06	2.41e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—UCP2—hypertension	1.45e-06	2.41e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ABCC1—hypertension	1.45e-06	2.41e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—UCP3—hypertension	1.45e-06	2.41e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—VEGFA—hypertension	1.42e-06	2.36e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ALAS1—hypertension	1.41e-06	2.33e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—SLC2A3—hypertension	1.41e-06	2.33e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CYP11B2—hypertension	1.41e-06	2.33e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ADA—hypertension	1.39e-06	2.3e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—HSD3B1—hypertension	1.39e-06	2.3e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—AQP1—hypertension	1.37e-06	2.26e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—FADS1—hypertension	1.37e-06	2.26e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—MYC—hypertension	1.35e-06	2.23e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—TGFB1—hypertension	1.34e-06	2.22e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CA9—hypertension	1.33e-06	2.2e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—TBXAS1—hypertension	1.33e-06	2.2e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—EGFR—hypertension	1.32e-06	2.18e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—MYC—hypertension	1.31e-06	2.17e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—TGFB1—hypertension	1.31e-06	2.16e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ALOX5AP—hypertension	1.29e-06	2.14e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ALOX15—hypertension	1.29e-06	2.14e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—EGFR—hypertension	1.28e-06	2.12e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—HADHA—hypertension	1.26e-06	2.09e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—LHB—hypertension	1.26e-06	2.09e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—KCNJ11—hypertension	1.24e-06	2.05e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—LPA—hypertension	1.24e-06	2.05e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—HSD3B2—hypertension	1.24e-06	2.05e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—LRP2—hypertension	1.18e-06	1.96e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CYP2C18—hypertension	1.18e-06	1.96e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—HSPG2—hypertension	1.14e-06	1.89e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—TP53—hypertension	1.11e-06	1.83e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ALOX5—hypertension	1.1e-06	1.82e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GLP1R—hypertension	1.1e-06	1.82e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—TP53—hypertension	1.08e-06	1.78e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—IL6—hypertension	1.01e-06	1.68e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ALDH2—hypertension	1.01e-06	1.67e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—IL6—hypertension	9.84e-07	1.63e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—HBA1—hypertension	9.81e-07	1.63e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CYP11A1—hypertension	9.75e-07	1.62e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GSTT1—hypertension	9.58e-07	1.59e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—SLC9A1—hypertension	9.58e-07	1.59e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GCLC—hypertension	9.47e-07	1.57e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CETP—hypertension	9.47e-07	1.57e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—AKT1—hypertension	9.33e-07	1.55e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—AKT1—hypertension	9.08e-07	1.5e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CYP17A1—hypertension	9.07e-07	1.5e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ENO1—hypertension	8.98e-07	1.49e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PTGS1—hypertension	8.98e-07	1.49e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CTGF—hypertension	8.64e-07	1.43e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—HMGCR—hypertension	8.56e-07	1.42e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GOT2—hypertension	8.56e-07	1.42e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ADRA2A—hypertension	8.38e-07	1.39e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—TH—hypertension	7.84e-07	1.3e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CALM2—hypertension	7.82e-07	1.29e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—SLC2A4—hypertension	7.63e-07	1.26e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GCG—hypertension	7.63e-07	1.26e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GOT1—hypertension	7.39e-07	1.22e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—STK11—hypertension	7.18e-07	1.19e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CYP19A1—hypertension	7.18e-07	1.19e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—COMT—hypertension	6.67e-07	1.1e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PPARGC1A—hypertension	6.58e-07	1.09e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GNB3—hypertension	6.58e-07	1.09e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—HMOX1—hypertension	6.55e-07	1.08e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CAT—hypertension	6.46e-07	1.07e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GNAS—hypertension	6.4e-07	1.06e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—APOB—hypertension	6.27e-07	1.04e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GSTM1—hypertension	6.1e-07	1.01e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—LPL—hypertension	5.99e-07	9.92e-06	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ADCY5—hypertension	5.86e-07	9.71e-06	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GPX1—hypertension	5.84e-07	9.68e-06	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PRKCA—hypertension	5.78e-07	9.58e-06	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CYP1A1—hypertension	5.78e-07	9.58e-06	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CD36—hypertension	5.69e-07	9.43e-06	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—MTHFR—hypertension	5.39e-07	8.93e-06	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PPARA—hypertension	5.29e-07	8.76e-06	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—AGT—hypertension	5.12e-07	8.49e-06	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CALM1—hypertension	5.04e-07	8.34e-06	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—APOE—hypertension	5.02e-07	8.31e-06	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CAV1—hypertension	4.97e-07	8.24e-06	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—APOA1—hypertension	4.96e-07	8.22e-06	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PPARG—hypertension	4.37e-07	7.24e-06	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—POMC—hypertension	4.31e-07	7.14e-06	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—INS—hypertension	4.29e-07	7.1e-06	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ALB—hypertension	3.93e-07	6.51e-06	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PIK3R1—hypertension	3.76e-07	6.23e-06	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—NOS3—hypertension	3.76e-07	6.23e-06	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PTGS2—hypertension	3.44e-07	5.7e-06	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PTEN—hypertension	3e-07	4.97e-06	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—EP300—hypertension	2.86e-07	4.74e-06	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—AKT1—hypertension	1.73e-07	2.86e-06	CbGpPWpGaD
